All nirmatrelvir/ritonavir articles
-
NewsNirmatrelvir/ritonavir antiviral combination shows potential in reducing COVID-19 hospitalizations
A systematic review aimed to summarize published evidence on the efficacy, effectiveness, and safety of nirmatrelvir/ritonavir for COVID-19. The review also intended to assess the robustness of the evidence from randomized controlled trials.
